EUVIMEDObjevte EUVIMED
Open access

Diagnostic Impacts of Aldehyde Dehydrogenase 2 Genetic Variants on Hepatocellular Carcinoma Susceptibility

Yu-Ting Chin, Ming-Hsien Wu, Hou-Yu Shih, Chia-Wen Tsai, Jen-Sheng Pei, Tao-Wei Ke, Yun-Chi Wang, Yi-Chih Hung, Jaw-Chyun Chen, DA-Tian Bau, Wen-Shin Chang

Cancer Diagnosis & Prognosis · 2024-09-01 · 4 (5) · 579-585

DOI: 10.21873/cdp.10366 ↗

At a glance

Journal article in Cancer Diagnosis & Prognosis, published online on 2024-09-01. Written by Yu-Ting Chin and 10 co-authors. Institution: Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C. Cited 3 times so far (Crossref). The full text is freely available in PubMed Central.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background/Aim: The role of alcohol consumption and aldehyde dehydrogenase 2 (ALDH2) genotype in hepatocellular carcinoma (HCC) development remains uncertain. Materials and Methods: We conducted genotyping of the ALDH2 rs671 single nucleotide polymorphism in 298 patients with HCC and 889 non-cancerous healthy controls. We assessed associations stratified by sex and alcohol consumption status. Results: Distribution of ALDH2 rs671 variant genotypes differed significantly between HCC patients and controls (ptrend=0.0311). Logistic regression analyses indicated that compared to the wild-type GG genotype, the heterozygous variant AG genotype and homozygous variant AA genotype conferred 1.22- and 1.77-fold increases in HCC risk (p=0.1794 and 0.0150, respectively). Allelic frequency analysis showed that the A allele was associated with a 1.29-fold increased HCC risk (p=0.0123). Additionally, AA genotype carriers had significantly higher HCC risk than GG genotype carriers among males (p=0.0145) and non-alcohol drinkers (p

Subjects

Author keywords

Alcohol drinkingaldehyde dehydrogenase 2 (ALDH2)genotypehepatocellular carcinomapolymorphism

Authors and institutions

  • Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.
  • Terry Fox Cancer Research Laboratory, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, R.O.C.
  • Division of Colon and Rectal Surgery, Taichung Armed Forces General Hospital, Taichung, Taiwan, R.O.C.
  • National Defense Medical Center, Taipei, Taiwan, R.O.C.
  • Department of Pediatrics, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, Taiwan, R.O.C.
  • Department of Medicinal Botanicals and Foods on Health Applications, Da-Yeh University, Changhua, Taiwan, R.O.C.

Cite

APA

Chin, Y. T., Wu, M. H., Shih, H. Y., Tsai, C. W., Pei, J. S., Ke, T. W., Wang, Y. C., Hung, Y. C., Chen, J. C., Bau, D. T., & Chang, W. S. (2024). Diagnostic Impacts of Aldehyde Dehydrogenase 2 Genetic Variants on Hepatocellular Carcinoma Susceptibility. Cancer Diagnosis & Prognosis, 4(5), 579-585. https://doi.org/10.21873/cdp.10366

Vancouver

Chin YT, Wu MH, Shih HY, Tsai CW, Pei JS, Ke TW, et al. Diagnostic Impacts of Aldehyde Dehydrogenase 2 Genetic Variants on Hepatocellular Carcinoma Susceptibility. Cancer Diagnosis & Prognosis. 2024;4(5):579-585. doi:10.21873/cdp.10366

BibTeX
@article{Chin2024,
  author = {Chin, Yu-Ting and Wu, Ming-Hsien and Shih, Hou-Yu and Tsai, Chia-Wen and Pei, Jen-Sheng and Ke, Tao-Wei and Wang, Yun-Chi and Hung, Yi-Chih and Chen, Jaw-Chyun and Bau, DA-Tian and Chang, Wen-Shin},
  title = {Diagnostic Impacts of Aldehyde Dehydrogenase 2 Genetic Variants on Hepatocellular Carcinoma Susceptibility},
  journal = {Cancer Diagnosis & Prognosis},
  year = {2024},
  volume = {4},
  number = {5},
  pages = {579--585},
  doi = {10.21873/cdp.10366}
}
Start for free →